Advertisement
Novinky na Forexu
Primoris Services Gets $270 Mln Solar Project Award
Primoris Services Corp. (PRIM) announced Tuesday a solar project award with an estimated value of $270 million. The contract was secured by the Company's Energy/Renewables Segment.
RTTNews |
Před 1107 dny
Eurozone Private Sector Shrinks For Second Month
Eurozone private sector contracted for the second straight month in August as the downturn in manufacturing continued and the service sector ground to a near-halt, flash survey results from S&P Global showed on Tuesday. The flash composite output index slid to 49.2 in August from 49.9 in July. However, the reading was slightly above the expected level of 49.0.
RTTNews
|
Před 1107 dny
Dole Q2 Adj. EPS Tops Estimates, But Revenues Miss; Slashes FY22 Outlook
Fresh produce supplier Dole plc (DOLE) reported Tuesday that net income attributable to Dole for the second quarter surged to $41.3 million or $0.43 per share from $29.2 million or $0.52 per share in the prior-year quarter. Excluding items, adjusted income was $0.44 per share, compared to $0.74 per share in the year-ago quarter.
RTTNews
|
Před 1107 dny
Pound Rebounds As U.K. Services PMI Beats Forecast
The pound erased its early losses against its major counterparts in the European session on Tuesday, as U.K. service sector activity rose more than expected in August.
RTTNews
|
Před 1107 dny
Bay Street Seen Opening On Mixed Note
Canadian shares are likely to open on a mixed note on Tuesday, tracking higher crude oil prices and weak European stocks.
RTTNews
|
Před 1107 dny
DICK'S Sporting Boosts FY22 Outlook As Q2 Results Top Estimates
While reporting financial results for the second quarter on Tuesday, sporting goods retailer DICK'S Sporting Goods Inc. (DKS) raised its earnings, adjusted earning and consolidated same store sales guidance for the full-year 2022.
RTTNews
|
Před 1107 dny
Foghorn Therapeutics Says FDA Places Clinical Hold On Phase 1 Dose Escalation Study Of FHD-286
Biotechnology company Foghorn Therapeutics Inc. (FHTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on the Phase 1 dose escalation study of FHD-286, an inhibitor of BRG1/BRM, in relapsed and/or refractory acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS).
RTTNews
|
Před 1107 dny
more news
JD.com Q2 Net Profit Soars; Revenue Up 5.4%
e-commerce company JD.com, Inc. (JD) reported Tuesday that net income attributable to ordinary shareholders for the second quarter was RMB4.38 billion or $0.65 billion, compared to RMB0.79 billion in the year-ago quarter. Net income per ADS was RMB2.74 or $0.41, compared to RMB0.50 last year.
RTTNews
|
Před 1107 dny
Medtronic Reiterates FY23 Outlook - Update
While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
RTTNews
|
Před 1107 dny
Sensex, Nifty End Choppy Session Higher; IT Stocks Bleed
Indian shares ended a choppy session modestly higher on Tuesday, tracking gains in European markets and the U.S. equity futures.
RTTNews
|
Před 1108 dny
European Shares Mixed After PMI Data
European stocks traded mixed in cautious trade on Tuesday as the deepening energy crisis in the region fueled recession fears.
RTTNews
|
Před 1108 dny
FTSE 100 Slides On Growth Worries
U.K. stocks were moving lower on Tuesday amid worries about rising inflation and its impact on economic growth.
RTTNews
|
Před 1108 dny
CAC 40 Edges Higher In Lackluster Trade
French stocks edged up slightly on Tuesday after suffering heavy losses in the previous session on worries that soaring inflation and aggressive policy tightening by central banks will continue to cripple growth.
RTTNews
|
Před 1108 dny
Stay up to date!
Add Zprávy to your browser
Add To Chrome
